Search

Author/Creator Buti, Maria

31. IDDF2018-ABS-0107 Efficacy and safety of TENOFOVIR ALAFENAMIDE (TAF) at 96 weeks in chronic HBV (CHB) patients with risk factors for use of TENOFOVIR DISOPROXIL FUMARATE (TDF). (June 2018)

Authors:
Chan, Henry Lik-Yuen; Buti, Maria; Flisiak, Robert; Ryder, Stephen; Streinu-Cercel, Adrian; Flaherty, John F; Gaggar, Anuj; Mo, Shuyuan; Mani Subramanian, G; Zoulim, Fabrian; Andreone, Pietro; Marcellin, Patrick
Journal:
Gut
Issue:
Volume 67(2018)Supplement 2
Page Start:
A97
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

32. IDDF2019-ABS-0134 Sofosbuvir/velpatasvir is effective and safe in patients with concomitant proton pump inhibitor use in clinical studies. (June 2019)

Authors:
Esteban, Rafael; Agarwal, Kosh; Calleja, Jose Luis; Dufour, Jean-Francois; Flamm, Steven; Gordon, Stuart; Stamm, Luisa; Ni, Liyun; Brainard, Diana; Sze Man Yip, Christina; Kowdley, Kris; Cooper, Curtis; Pineda, Juan Antonio; Castells, Lluis; Buti, Maria; Lens, Sabela
Journal:
Gut
Issue:
Volume 68(2019)Supplement 1
Page Start:
A137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

33. IDDF2019-ABS-0168 Bone and renal safety are improved in chronic hbv patients 1 year after switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF). (June 2019)

Authors:
Lik Yuen Chan, Henry; Seto, Wai Kay; Buti, Maria; Izumi, Namiki; Lim, Young-Suk; Kao, Jia-Horng; Streinu-Cercel, Adrian; Nurmukhametova, Elena; Ma, Xiaoli; Tabak, Fehmi; Jablkowski, Maciej; Suri, Vithika; Flaherty, John; Lau, Audrey; Gaggar, Anuj; Mo, Shuyuan; Chowdhury, Abhijit; Fung, Scott; Chu...
Journal:
Gut
Issue:
Volume 68(2019)Supplement 1
Page Start:
A141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

34. IDDF2019-ABS-0169 A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results. (June 2019)

Authors:
Lik Yuen Chan, Henry; Lampertico, Pietro; Buti, Maria; Fung, Scott; Ahn, Sang Hoon; Chuang, Wan-Long; Tak, Won Young; Ramji, Alnoor; Chen, Chi-Yi; Tam, Edward; Bae, Ho; Ma, Xiaoli; Flaherty, John; Gaggar, Anuj; Lau, Audrey; Feierbach, Becket; Wu, George; Suri, Vithika; Subramanian, Mani; Trinh, Huy
Journal:
Gut
Issue:
Volume 68(2019)Supplement 1
Page Start:
A142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. IDDF2019-ABS-0210 Preliminary efficacy and safety of 8-week glecaprevir/pibrentasvir in patients with HCV genotype 1–6 infection and compensated cirrhosis: the EXPEDITION-8 study. (June 2019)

Authors:
Brown, Robert S; Hezode, Christopher; Wang, Stanley; Buti, Maria; Chuang, Wan-Long; Aguilar, Humberto; Horvath, Gabor; Carrion, Barbara Rosado; Rodriguez-Perez, Federico; Cohen, Eric; Hu, Yiran B; Schnell, Gretja; Lin, Chih-Wei; Rodrigues, Lino; Trinh, Roger; Mensa, Federico J
Journal:
Gut
Issue:
Volume 68(2019)Supplement 1
Page Start:
A146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

36. IDDF2020-ABS-0060 Impact of prior tenofovir disoproxil fumarate (TDF) treatment duration on tenofovir alafenamide (TAF) safety profile in virally suppressed chronic HBV patients switched from TDF to TAF. (18th November 2020)

Authors:
Yuen Chan, Henry Lik; Lampertico, Pietro; Ahn, Sang Hoon; Fung, Scott; Bae, Ho; Ramji, Alnoor; Lee, Jung Sung; Shafran, Stephen; Gordon, Stuart; Phan, Charles; Tan, Susanna; Flaherty, John; Gaggar, Anuj; Wu, George; Suri, Vithika; Lau, Daryl; Byun, Kwan Soo; Agarwal, Kosh; Lim, Young-Suk; Buti, M...
Journal:
Gut
Issue:
Volume 69(2020)Supplement 2
Page Start:
A74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

37. IDDF2020-ABS-0061 Impact of treatment with tenofovir alafenamide (TAF) or tenofovir disoproxil fumarate (TDF) on hepatocellular carcinoma (HCC) incidence in patients with chronic hepatitis B (CHB). (18th November 2020)

Authors:
Yuen Chan, Henry Lik; Lim, Young-Suk; Seto, Wai Kay; Ning, Qin; Agarwal, Kosh; Janssen, Harry LA; Pan, Calvin O; Chuang, Wan Long; Izumi, Namiki; Fung, Scott; Brunetto, Maurizia; Flaherty, John; Mo, Shuyuan; Cheng, Cong; Lin, Lanjia; Gaggar, Anuj; Subramanian, Mani; Marcellin, Patrick; Gane, Edwa...
Journal:
Gut
Issue:
Volume 69(2020)Supplement 2
Page Start:
A75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

38. Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Issue 20 (15th July 2015)

Authors:
Kim, W. Ray; Loomba, Rohit; Berg, Thomas; Aguilar Schall, Raul E.; Yee, Leland J.; Dinh, Phillip V.; Flaherty, John F.; Martins, Eduardo B.; Therneau, Terry M.; Jacobson, Ira; Fung, Scott; Gurel, Selim; Buti, Maria; Marcellin, Patrick
Journal:
Cancer
Issue:
Volume 121:Issue 20(2015)
Page Start:
3631
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

39. Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B. (17th May 2021)

Authors:
Hsu, Yao-Chun; Yeh, Ming-Lun; Wong, Grace Lai-Hung; Chen, Chien-Hung; Peng, Cheng-Yuan; Buti, Maria; Enomoto, Masaru; Xie, Qing; Trinh, Huy; Preda, Carmen; Liu, Li; Cheung, Ka-Shing; Yeo, Yee Hui; Hoang, Joseph; Huang, Chung-Feng; Riveiro-Barciela, Mar; Kozuka, Ritsuzo; Istratescu, Doina; Tsai, P...
Journal:
Journal of infectious diseases
Issue:
Volume 224:Number 11(2021)
Page Start:
1890
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

40. Incremental value of HBcrAg to classify 1582 HBeAg‐negative individuals in chronic infection without liver disease or hepatitis. Issue 6 (19th January 2021)

Authors:
Brunetto, Maurizia R.; Carey, Ivana; Maasoumy, Benjamin; Marcos‐Fosch, Cristina; Boonstra, André; Caviglia, Gian Paolo; Loglio, Alessandro; Cavallone, Daniela; Scholtes, Caroline; Ricco, Gabriele; Smedile, Antonina; Riveiro‐Barciela, Mar; van Bömmel, Florian; van der Eijk, Annemiek; Zoulim, Fabie...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 53:Issue 6(2021)
Page Start:
733
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗